Windtree Therapeutics, Inc.

Windtree Therapeutics is a biopharmaceutical company dedicated to developing innovative treatments for oncology and cardiovascular diseases, focusing on areas with significant unmet medical needs. Their lead asset, istaroxime, is a first-in-class intravenous agent designed to improve cardiac function by increasing both systolic contractions and diastolic relaxation of the heart. Istaroxime has shown promising results in clinical trials for acute heart failure (AHF) and early cardiogenic shock (ECS), and Windtree is actively seeking partners to advance its development.

Beyond istaroxime, Windtree is also developing a portfolio of SERCA2a activators, which have the potential to provide both acute and chronic treatment for heart failure. Additionally, the company has acquired a novel protein kinase C iota inhibitor platform for oncology, which they plan to advance this year. Windtree has a global reach, with operations in Warrington, PA, Taiwan, and Milan, Italy, and they are actively exploring potential licensing transactions, strategic alliances, and acquisitions to grow their business and bring their innovative therapies to patients in need.

Windtree Therapeutics is a biopharmaceutical company dedicated to developing innovative treatments for patients with significant unmet medical needs in oncology and cardiovascular disease. Their mission is to deliver novel therapies that significantly improve upon current standards of care, particularly for those suffering from acute conditions like heart failure, cardiogenic shock, lung injury, and neonatal respiratory distress. The company strives to develop life-saving innovations and deliver them responsibly with a focus on quality and access to care.

Windtree Therapeutics promotes a culture of diversity, inclusion, and innovation, valuing the input and contributions of team members from diverse backgrounds and experiences. They encourage a welcoming environment where everyone feels a sense of belonging and is treated with mutual respect, fostering open communication and respectful debates to inspire better problem-solving and innovation.

Windtree Therapeutics acknowledges the value of a diverse workforce, believing that different backgrounds and experiences lead to greater innovation and problem-solving. They foster a culture of inclusivity and respect, where all voices are valued and everyone feels a sense of belonging. To support this, they focus on diversity and inclusion in hiring and retention practices, encouraging open communication and respectful debate where all team members feel comfortable sharing their perspectives.